Journal of Interferon & Cytokine Research · 1995 · 16 citations · 24 references
PharmacyPharmacokineticsPharmacologyBioavailabilityHepatic PharmacokineticsMolecular PharmacologyDrug DispositionIn Vitro PharmacologyAsparagine-linked Glycosylation
Glycoproteins are metabolized through an asialoglycoprotein metabolic pathway in vivo. They are desialylated and taken up by the liver via an asialoglycoprotein receptor. Fibroblast-derived natural human interferon-beta is a glycoprotein having a single asparagine-linked sugar chain. Although natural human interferon-beta may also be metabolized through this pathway, there is very little information about the biologic features of human asialointerferon-beta. We evaluated the pharmacokinetics and biologic activities of human native and asialointerferon-beta s. After intravenous administration to rabbits, human asialointerferon-beta was cleared from the blood circulation faster than the human native interferon-beta. More asialoprotein was distributed to the liver than the native type, but it induced less 2'5'-oligoadenylate synthetase. The human asialointerferon-beta had less activity than the human native interferon-beta on cell growth inhibition and 2'5'-oligoadenylate synthetase induction in Hep-G2 and HuH6 human hepatoblastoma cells. Southern blotting using a hepatitis B virus-transfected HuH6 cell line, HB611, revealed that the inhibition of hepatitis B virus DNA replication by the asialoprotein was weaker than that by the native protein. The results showed that the different effects exerted by the human native and asialointerferon-beta s may be a result of recognition of the sugar chains by rabbit hepatocytes or by human hepatoblastoma cells. The results also suggested that the terminal sialic acid of the sugar chains in natural human interferon-beta significantly affects its pharmacokinetics and biologic activities.
24
Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.
Hidekazu Nakabayashi, Kazuhisa Taketa, Keiko Miyano et al. · PubMed · 1982 · 1.4K citations
Medicine, Cell Biology, Oncology +10
Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
David P. Aden, Alice Fogel, Stanley A. Plotkin et al. · Nature · 1979 · 1.3K citations
Medicine, Biochemistry, Oncology +5
E D Green, Gabriela Adelt, Jacques Baenziger et al. · Journal of Biological Chemistry · 1988 · 443 citations · Full text
Survival of recombinant erythropoietin in the circulation: the role of carbohydrates
MN Fukuda, H Sasaki, Lydia Bisbal Lopez et al. · Blood · 1989 · 345 citations · Full text
Survival of recombinant erythropoietin in the circulation: the role of carbohydrates
MN Fukuda, H Sasaki, Lydia Bisbal Lopez et al. · Blood · 1989 · 334 citations